Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale

Stroke

Volumn 35, Issue 9, 2004, Pages 2145-2149

  Homma, Shunichi ^a,c   DiTullio, Marco R ^a   Sacco, Ralph L ^b   Sciacca, Robert R ^a   Mohr, J P ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

Aspirin; Echocardiography; Stoke; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STROKE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WARFARIN;

EID: 4344694354     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000135773.24116.18     Document Type: Article

References (27)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
2. DiTullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992;117:461-465.
3. Mas JL, Zuber M, for the French study group on patent foramen ovale and atrial septal aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale or atrial septal aneurysm, or both and cryptogenic stroke or TIA. Am Heart J. 1995;130:1083-1088.
4. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. for the Lausanne Stroke Registry Group. Stroke recurrence in patients with patent foramen ovale. Neurology. 1996;46:1301-1305.
5. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
6. Homma S, Sacco RL, DiTullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with PFO: PFO in cryptogenic stroke study. Circulation. 2002;105:2625-2631.
7. Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
8. Anderson SI, Housley AM, Jones PA, Slattery J, Miller JD. Glasgow outcome scale: an inter-rater reliability study. Brain Inj. 1993;7:309-317.
9. Adams HP Jr, Bendixen B, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke-definitions for use in a multicenter clinical trial, TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
10. DiTullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24:1020-1024.
11. Kerr AJ, Buck T, Chia K, Chow CM, Fox E, Levine RA, Picard MH. Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantification. J Am Coll Cardiol. 2000;36:1959-1966.
12. De Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol. 1992;69:1316-1320.
13. Jones EF, Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol. 1994;74:596-599.
14. Chatuverdi S. Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci. 1998;160:158-160.
15. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, Akkawi NM, Albertini A, Assanelli D, Vignolo LA, Padovani A. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28-33.
16. Stöllberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119:461-465.
17. Schina MJ, Meumyer MM, Healy DA, Atnip RG, Thiele BL. Influence of age on venous physiologic parameters. J Vasc Surg. 1993;18:749-752.
18. Nurmohahed MT, Buller HR, ten Cate JW. Physiological changes due to age: implications for the prevention and treatment of thrombosis in older patients. Drugs & Aging. 1994;5:20-33.
19. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest. 1996;98:899-905.
20. Vilén L, Jacobsson S, Wadenvik H, Kutti J. ADP-induced platelet aggregation as a function of age in healthy humans. Thromb Haemost. 1989;61:490-492.
21. Brendan M, McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104:2797-2802.
22. Dib JC, Abergel E, Rovani C, Raffoul H, Diebold B. The age of the patient should be taken into account when interpreting Doppler assessed pulmonary artery pressures. J Am Soc Echocardiog. 1997;10:72-73.
23. Homma S, DiTullio MR, Sacco RL, Smith C, Mohr JP. Surgical closure of patent foramen ovale in selected patients with cryptogenic stroke: a preliminary study. Stroke. 1997;28:2376-2381.
24. Martín F, Sánchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106:1121-1126.
25. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation. 2002;105:2845-2848.
26. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation. 2003;107:5-9.
27. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000;53:786-792.